EMBioSys has developed Efinia™, a revolutionary platform for the treatment of cancer with the potential to dramatically improve clinical outcomes as a new cancer treatment modality starting with breast cancer...then other solid tumors. Efinia™ delivers iEF Therapy (low intensity induced electric fields) to the treat the patient from the comfort of home, or while on the go. Our vision is to empower patients and providers with a new standard of cancer care.
| Website | https://www.embiosys.com/ |
| Employees | 4 (2 on RocketReach) |
| Founded | 2022 |
| Phone | +1 978-771-4662 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Wearable Technology, Cancer Treatment, Solid Tumor Treatment, Cancer Therapies, Oncology Technology, Medical Devices, Medical Wearable, Platform Technology, Healthcare Technology, Biomedical Engineering |
Looking for a particular EMBioSys employee's phone or email?
Chris Barron is the Co-Founder and CEO of EMBioSys.
2 people are employed at EMBioSys.